Term
ACTH-dependent Cushing Syndrome |
|
Definition
endogenous hypercortisolism caused by:
pituitary adenoma (Cushing disease, CRH-dependent pituitary hyperplasia)
ectopic corticotropin syndrome (pulmonary small cell carcinoma, bronchial carcinoid)
bilateral diffuse hyperplasia of adrenal cortex
expanded lipid poor zona reticularis = compact, eosinophilic cells surrounded by an outer zone of vacuolated lipid-rich cells, like those in the ZF |
|
|
Term
ACTH-independent Cushing syndrome |
|
Definition
Hypercortisolism caused by:
Adrenal adenoma
Adrenal carcinoma
macronodular hyperplasia (ectopic expression of hormone receptors, including GIPR, LHR, vasopressin, and serotonin receptors)
primary pigmented nodular adrenal disease (PRKARIA, PDE11 mutations)
McCune-Albright syndrome (GNAS mutations)
morphologically |
|
|
Term
Exogenous glucocorticoid Cushing syndrome |
|
Definition
hypercortisolism with cortical atrophy characterized by a
zona glomerulosa of normal thickness and an atrophied zona fasciculata and reticularis
often encountered in steroid abuse |
|
|
Term
|
Definition
ACTH-indendepent cause of Cushing syndrome
replacement of adrenals with prominent nodules of varying sizes containing an admixture of lipid-poor and lipid-rich cells
areas between the prominent nodules also demonstrate evidence of microscopic nodularity |
|
|
Term
|
Definition
ACTH-independent cause of Cushing syndrome
adrenal is replaced by darkly pigmented (brown/black) micronodules with atrophic intervening areas
lipofuscin pigment from wear and tear |
|
|
Term
Primary adrenocortical neoplasms |
|
Definition
ACTH-independent cause of Cushing syndrome
includes benign and malignant neoplasms
Adenomas = yellow tumors with thin or well-developed capsule composed of cells similar to ZF
Carcinomas = larger than adenomas unencapsulated
**if functional, adjacent adrenal cortex and contralateral adrenal gland are atrophic due to suppression of endogenous ACTH by high cortisol levels |
|
|
Term
|
Definition
hypertension and weight gain
central pattern of fat deposition (truncal obesity), buffalo hump, moon facies
atrophy of fast-twitch myofibers
hyperglycemia, glucosuria, polydipsia (secondary diabetes)
easily bruised skin,abdominal striae, osteoporosis (due to loss of collagen and bone resorption)
mental disturbances (mood swings, depression, psychosis)
hirsutism, menstrual abnormalities |
|
|
Term
Bilateral idiopathic hyperaldosteronism |
|
Definition
bilateral nodular hyperplasia of the adrenal glands
cause of primary hyperaldosteronism
unclear pathogenesis
diffuse and focal hyperplasia of ZG-like cells
hyperplasia is often wedge-shaped, from periphery to center
increased aldosterone, decreased plasma renin |
|
|
Term
|
Definition
aldosterone-producing adenoma or adrenocortical carcinoma
cause of primary hyperaldosteronism
|
|
|
Term
|
Definition
primary hyperaldosteronism caused by a solitary adosterone-secreting adenoma |
|
|
Term
Glucocorticoid-remediable hyperaldosteronism |
|
Definition
uncommon cause of familial primary hyperaldosteronism
caused by chimeric gene with fusion of 11β-hydroxylase gene and aldosterone synthase gene (CYP11B1-CYP11B2)
leads to sustained production of hybrid steroids in addition to cortisol and aldosterone
suppressible by exogenous dexamethasone administration |
|
|
Term
|
Definition
general syndrome characterized by hypertension and potential hypokalemia from renal potassium wasting
aldosterone contributes to endothelial dysfunction by decreasing G6PD levels, which leads to reduced NO synthesis and causes oxidative stress
dx by elevated ratio of aldosterone:renin; confirm with aldosterone suppression test
adenomas are resected surgically; otherwise, spironolactone |
|
|
Term
Salt wasting adrenogenitalism
(21-hydroxylase deficiency) |
|
Definition
adrenogenital syndrome characterized by total lack of 21-hydroxylase
no hydroxlase to convert progesterone into deoxycorticosterone thus, no synthesis of mineralocorticoids
no mineralocorticoids leads to block in conversion of hydroxyprogesterone into deoxycorticosterol resulting in NO cortisol synthesis
presents soon after birth with salt wasting, hyponatremia, hyperkalemia
acidosis, hypotension, cardiovascular collapse, death
female virilization, male salt-wasting |
|
|
Term
Simple virilizing adrenogenitalism
(21-hydroxylase deficiency) |
|
Definition
adrenogenital syndrome that presents as genital ambiguity
some mineralocorticoid synthesis; no salt wasting
failure of feedback inhibition of ACTH secretion due to decreased glucocorticoid levels
leads to excess testosterone and progressive virilization |
|
|
Term
Nonclassic (late-onset) Adrenogenitalism |
|
Definition
adrenogenital syndrome with only partial deficiency in 21-hydroxylase
more common than classic patterns with a later onset
asymptomatic or mild symptoms, such as hirsutism, acne, menstrual irregularites
cannot be diagnosed on routine newborn screening |
|
|
Term
Congenital adrenal hyperplasia |
|
Definition
adrenogenital morphology includes bilaterally hyperplastic adrenals
cortex is thickened and nodular, appears brown
proliferating cells are compact, eosinophilic, lipid-depleted cells intermixed with lipid-laden clear cells
hyperplastic corticotroph cells in anterior pituitary
usually present with ambiguous genitalia, clitoral hypertrophy, pseudohermaphroditism, hirsutism, acne
(symptoms all related to androgen excess)
tx with exogenous glucocorticoids with addition of mineralocorticoid supplementation in salt-wasting variant |
|
|
Term
Waterhouse-Friderichsen Syndrome |
|
Definition
rapidly developing adrenocortical insufficiency characterized by overwhelming bacterial infection (classically N. meningitidis septicemia), rapidly progressing hypotension (leading to shock), and DIC (widespread purpura of the skin)
bilateral massive hemorrhage of the adrenals
more common in children, adrenals turn to sacs of clotted blood; hemorrhage starts in medulla near venous sinuses
can be treated with antibiotics, but if not recognized promptly, clinical course is abrupt and devastating |
|
|
Term
Addison Disease
(chronic adrenocortical insufficiency) |
|
Definition
progressive destruction of the adrenal cortex
caused by:
autoimmune adrenalitis = irregularly shrunken glands, often with antibodies to 21-hydroxylase or 17-hydroxylase
tuberculosis = granulomatous inflammation
mestastic carcinoma = enlarged adrenals
AIDS
progressive weakness, easy fatigability, GI disturbances, hyperpigmentation
decreased minerolcorticoid activity: hyperkalemia, hyponatremia, volume depletion, hypotension
stress can precipitate an acute adrenal crisis |
|
|
Term
Autoimmune polyendocrine syndrome type 1 (APS1) |
|
Definition
autoimmune disorder characterized by:
chronic mucocutaneous candidiasis
skin, dental enamel, and nail abnormalities (ectodermal dystrophy)
organ specific autoimmune disorders (esp. autoimmune adrenalitis --> causes primary adrenocortical insufficiency/Addison disease)
caused by mutation in AIRE gene on chr 21q22
compromise of central tolerance |
|
|
Term
Autoimmune polyendocrine syndrome type 2 (APS2) |
|
Definition
autoimmune syndrome that starts in early adulthood
presents as a combo of adrenal insufficiency and autoimmune thyroiditis or type 1 diabetes
NO autoimmune hypoparathyroidism, candidiasis, or ectodermal dysplasia |
|
|
Term
Secondary adrenocortical insufficiency |
|
Definition
caused by any disorder of the hypothalamus or pituitary that causes decreased ACTH
NO hyperpigmentation
deficient cortisol and androgen output, but near-normal aldosterone synthesis
moderately to markedly reduced size of adrenals
cortex may only be thin ribbon of mainly ZG |
|
|
Term
|
Definition
usually an incidentally found tumor
well-circumscribed, nodular lesions that expands the adrenal
functional = atrophy of adjacent cortex; nonfunctional = cortex is normal
usually yellow to yellow-brown
neoplastic cells are vacuolated due to intracytoplasmic lipid
mild nuclear pleomorphism (endocrine atypia) |
|
|
Term
Adrenocortical carcinomas |
|
Definition
more common in children
more likely functional, often associated with virilism
large, invasive lesion with marked anaplasia
on cut section, typically variegated, poorly demarcated with areas of necrosis, hemorrhage, and cystic change
have a strong tendency to invade the adrenal vein, vena cava, and lymphatics
metastases to regional and periaortic nodes are common
hematogenous spread to lungs and other viscera is common |
|
|
Term
|
Definition
benign lesions of the adrenals composed of mature fat and hematopoietic cells |
|
|
Term
|
Definition
neoplasm of the adrenal medulla composed of chromaffin cells, which release catecholamines and peptide hormones
rule of 10's: 10% extra-adrenal, 10% are bilateral, 10% are malignant, 10% assoc. w/ hypertension, 10% familial (now 25%)
have richly vascular fibrous trabeculae, lobular pattern
smaller lesions are yellow-tan; larger lesions are hemorrhagic, necrotic, cystic, typically efface the whole gland
incubation with potassium dichromate turns the tumor brown due to oxidation of stored catecholamines
polygonal to spindle-shaped chromaffin or chief cells clustered into small nests (zellballen)
round to ovoid nuclei, salt and pepper chromatin
malignancy is determined solely by metastases
hypertension w/ paroxysmal episodes
dx by increased urinary excretion of catecholamines their metabolites (vanillylmandelic acid, metanephrines) |
|
|
Term
Multiple endocrine neoplasia type 1
(Wermer syndrome) |
|
Definition
3 P's: parathyroid, pancreas, pituitary glands
Parathyroid: primary hyperparathyroidism; monoclonal hyperplasia or adenomas
Pancreas: aggressive endocrine tumors, often metastatic; pancreatic polypeptide is commonly secreted
Pituitary: prolactinoma; sometimes acromegaly due to somatotrophin secreting tumor
often a gastrinoma in the duodenum
mutation in MEN1, encoding menin
clinical picture dominated by effects of secreted hormones |
|
|
Term
Multiple endocrine neoplasia type 2A
(Sipple syndrome) |
|
Definition
pheochromocytoma, medullary carcinoma, parathyroid hyperplasia
medullary carcinoma = assoc. w/ C cell hyperplasia of the adjacent thyroid
Pheochromocytoma = 50%, often bilateral
Gain of function mutation in RET proto-oncogene on chr 10q11.2
early screening is important to allow for thyroidectomy if necessary |
|
|
Term
Multiple Endocrine Neoplasia Type 2B
(MEN-2B) |
|
Definition
medullary thyroid carcinoma (more aggressive) and pheochromocytomas
NO PRIMARY HYPERPARATHYROIDISM
in addition, neuromas or ganglioneuromas and a marfinoid habitus
amino acid substitution on RET leads to autophosphorylation and constitutive activation of RET |
|
|
Term
Familial medullary thyroid cancer |
|
Definition
variant of MEN-2A
strong predisposition to medullary thyroid cancer but no other clinical manifestations |
|
|
Term
Secondary Hyperaldosteronism |
|
Definition
hyperaldosteronism distinguished by INCREASED levels of renin
encountered in conditions of:
decreased renal perfusion = arteriolar nephrosclerosis, renal artery stenosis
arterial hypovolemia and edema = congestive heart failure, cirrhosis, nephrotic syndrome
pregancy = due to estrogen-induced increases in plasma renin substrate |
|
|
Term
Congenital Adrenal Hyperplasia |
|
Definition
autosomal-recessive inherited metabolic error characterized by a loss of enzyme in the biosynthesis of cortical steroids, especially cortisol
21-hydroxylase deficiency is responsible for 90% of cases:
defective conversion of progesterone to 11-DOC
high frequency in Hispanics and Ashkenazi Jews
gene inactivation involves recombination of CYP21A2 with a neighboring pseudogene on chr 6p21 called CYP21A1
can result in three syndromes: salt wasting, simple virilizing, or nonclassic |
|
|